222 related articles for article (PubMed ID: 17724313)
1. Human papillomavirus vaccine: waiting for a miracle.
MacDonald N; Hébert PC
CMAJ; 2007 Aug; 177(5):433, 435. PubMed ID: 17724313
[No Abstract] [Full Text] [Related]
2. Human papillomavirus, vaccines and women's health: questions and cautions.
Lippman A; Melnychuk R; Shimmin C; Boscoe M
CMAJ; 2007 Aug; 177(5):484-7. PubMed ID: 17671239
[No Abstract] [Full Text] [Related]
3. Latin America. Price is the main barrier to wider use of papillomavirus vaccine.
Kaiser J
Science; 2008 May; 320(5878):860. PubMed ID: 18487164
[No Abstract] [Full Text] [Related]
4. [EUROGIN 2010: roadmap on cervical cancer prevention].
Monsonego J
Gynecol Obstet Fertil; 2011; 39(7-8):462-7. PubMed ID: 21764621
[No Abstract] [Full Text] [Related]
5. Doubts on the appropriateness of universal human papillomavirus vaccination: is evidence on public health benefits already available?
Porta M; González B; Márquez S; Artazcoz L
J Epidemiol Community Health; 2008 Aug; 62(8):667. PubMed ID: 18621949
[No Abstract] [Full Text] [Related]
6. [Papillomavirus vaccines now allowed--ethical and logistical considerations].
Höpfl R
J Dtsch Dermatol Ges; 2007 May; 5(5):349-52. PubMed ID: 17451379
[No Abstract] [Full Text] [Related]
7. [Advisory report from the Health Council of the Netherlands to include human papillomavirus vaccination in the national immunisation programme for the prevention of cervical cancer].
Stekelenburg J; Schagen van Leeuwen J
Ned Tijdschr Geneeskd; 2008 Jul; 152(30):1701-2; author reply 1702. PubMed ID: 18717015
[No Abstract] [Full Text] [Related]
8. Commentary: Health inequity could increase in poor countries if universal HPV vaccination is not adopted.
Franco EL
BMJ; 2007 Aug; 335(7616):378-9. PubMed ID: 17717367
[No Abstract] [Full Text] [Related]
9. Anticipating full benefits from the new papillomavirus vaccines.
Griffiths PD
Rev Med Virol; 2007; 17(1):1-3. PubMed ID: 17173349
[No Abstract] [Full Text] [Related]
10. Two new vaccines: Gardasil and Rotateq.
Van Gilder D
S D Med; 2007 Jan; 60(1):13-4. PubMed ID: 17319292
[No Abstract] [Full Text] [Related]
11. Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications.
Goldie SJ; O'Shea M; Diaz M; Kim SY
Reprod Health Matters; 2008 Nov; 16(32):86-96. PubMed ID: 19027626
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus vaccine.
Suba EJ; Raab SS;
N Engl J Med; 2007 Sep; 357(11):1155; author reply 1155-6. PubMed ID: 17874469
[No Abstract] [Full Text] [Related]
13. Examining mandatory HPV vaccination for all school-aged children.
Skov RE
Food Drug Law J; 2007; 62(4):805-29. PubMed ID: 18557231
[No Abstract] [Full Text] [Related]
14. Towards global prevention of human papillomavirus-induced cancer.
Roden RB; Gravitt P; Wu TC
Eur J Immunol; 2008 Feb; 38(2):323-6. PubMed ID: 18228245
[No Abstract] [Full Text] [Related]
15. The ethics and politics of compulsory HPV vaccination.
Colgrove J
N Engl J Med; 2006 Dec; 355(23):2389-91. PubMed ID: 17151362
[No Abstract] [Full Text] [Related]
16. [Introduction of vaccination against human papillomavirus in developing countries: update and perspectives].
Hessel L
Med Trop (Mars); 2009 Aug; 69(4):323-6. PubMed ID: 19725378
[TBL] [Abstract][Full Text] [Related]
17. Herd immunity.
O'Connor K
Aust Fam Physician; 2007 Sep; 36(9):677. PubMed ID: 17915372
[No Abstract] [Full Text] [Related]
18. Compulsory HPV vaccination.
Basu S
N Engl J Med; 2007 Mar; 356(10):1074; author reply 1074-5. PubMed ID: 17347466
[No Abstract] [Full Text] [Related]
19. HPV vaccine: beyond the hype.
Consum Rep; 2007 Oct; 72(10):47. PubMed ID: 17912799
[No Abstract] [Full Text] [Related]
20. One in four California adolescent girls have had human papillomavirus vaccination.
Grant D; Kravitz-Wirtz N; Breen N; Tiro JA; Tsui J
Policy Brief UCLA Cent Health Policy Res; 2009 Feb; (PB2009-3):1-6. PubMed ID: 19288623
[No Abstract] [Full Text] [Related]
[Next] [New Search]
